Keywords: gsk, lamictal, xr, cut, partial, seizures, data

GSK's Lamictal XR cut partial seizures 46%

Article | 14 May 2007

Print This

Data from two clinical trials presented at the American Academy of Neurology meeting in Boston suggest that an investigational once-daily ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in